Related Experiment Videos

Pediatric poststernotomy mediastinitis

Abdullah A Al-Sehly1, Joan L Robinson, Bonita E Lee

  • 1Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.

Insights

Delayed sternal closure is not a significant risk factor for mediastinitis in pediatric cardiac surgery patients. Effective treatment involves debridement and primary closure, leading to excellent outcomes.

Area of Science:

  • Pediatric Cardiac Surgery
  • Infectious Disease Management
  • Thoracic Surgery

Background:

  • Mediastinitis poses significant morbidity in pediatric cardiac surgery patients.
  • The role of delayed sternal closure as a risk factor for mediastinitis is unclear.
  • Current management strategies for mediastinitis are debated.

Purpose of the Study:

  • To investigate the association between delayed sternal closure and mediastinitis in pediatric cardiac surgery.
  • To evaluate the outcomes of mediastinitis management in this patient population.

Main Methods:

  • Retrospective review of pediatric mediastinitis cases from 1991 to 2004.
  • Analysis of infection incidence, timing, and risk factors, including sternal closure method.
  • Evaluation of clinical signs and treatment outcomes.

Main Results:

  • The incidence of mediastinitis was 1.1% (29 cases in 2,675 procedures).
  • Delayed sternal closure showed an odds ratio of 1.88 (not statistically significant) for infection.
  • Common signs included fever, erythema, purulent drainage, and wound dehiscence.

Conclusions:

  • Delayed sternal closure is not a major risk factor for pediatric cardiac surgery-associated mediastinitis.
  • Debridement and primary closure yield excellent results for treating mediastinitis.
  • Primary skin closure with delayed sternal closure may mitigate risks.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: